Stay updated on pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.

Latest updates to the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page
- Check7 days agoChange DetectedThe page no longer lists the condition 'Prostate cancer' and removes the related topics entry for 'MedlinePlus Genetics'.SummaryDifference0.2%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedProstate cancer and related topics: MedlinePlus Genetics were added as related topics, and the revision note was updated from v3.5.3 to v3.5.4.SummaryDifference0.2%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedThis update adjusts the ClinicalTrials.gov page footer revision/version text and removes/adds some surrounding MedlinePlus/related topics messaging. These are presentation or housekeeping elements and do not change the study content or the information participants would use to evaluate the trial.SummaryDifference0.2%

- Check50 days agoChange DetectedAdded Prostate cancer tag and MedlinePlus Genetics related topic; updated page revision to v3.5.2 (replacing v3.5.0).SummaryDifference0.2%

- Check57 days agoChange DetectedCore disease term 'Prostate cancer' and the related topic 'MedlinePlus Genetics' were removed from the page. This reduces the subject context and linked informational resources for readers.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded related topics 'Prostate cancer' and 'MedlinePlus Genetics' to the page's topics/related-links section.SummaryDifference0.2%

Stay in the know with updates to pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the pTVG-HP & Nivolumab in Prostate Cancer Clinical Trial page.